Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT01336920
Brief Title:
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Official Title:
Phase I Study of Carfilzomib for the Treatment of T-Cell Lymphoma
Study:
NCT01336920
Protocol Section:
NCT01336920